Mark Brian Anderson - Net Worth and Insider Trading

Mark Brian Anderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Brian Anderson owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .

Click here to see the complete history of Mark Brian Anderson’s form 4 insider trades.

Insider Ownership Summary of Mark Brian Anderson

Ticker Comapny Transaction Date Type of Owner
NBY NovaBay Pharmaceuticals Inc 2009-10-15 CSO

Mark Brian Anderson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Brian Anderson Ownership Network

Ownership Network List of Mark Brian Anderson

No Data

Ownership Network Relation of Mark Brian Anderson

Insider Network Chart

Mark Brian Anderson Owned Company Details

What does NovaBay Pharmaceuticals Inc do?

Who are the key executives at NovaBay Pharmaceuticals Inc?

Mark Brian Anderson is the CSO of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .

NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

NovaBay Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Brian Anderson Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Brian Anderson. You might contact Mark Brian Anderson via mailing address: 5980 Horton Street, Suite 550, Emeryville Ca 94608.

Discussions on Mark Brian Anderson

No discussions yet.